uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Ruxolitinib Viatris
Opinion
Human
Details
EMA number
EMEA/H/C/006618
ATC code
L01EJ01
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of myelofibrosis (MF), polycythaemia vera (PV) and Graft versus host disease (GvHD).
MeSH:
Primary Myelofibrosis;Polycythemia Vera;Graft vs Host Disease
Group:
Antineoplastic agents
Active substances
ruxolitinib hemifumarate
Marketing Authorisation Holder
Viatris Limited
MAH
Ruxolitinib Viatris | uMedical